Deepened cellular/subcellular interface penetration and enhanced antitumor efficacy of cyclic peptidic ligand-decorated accelerating active targeted nanomedicines

References

• StewartBWKleihuesPWorld Cancer ReportGenevaWorld Health Organization Press2003
   Google Scholar
• PeerDKarpJMHongSNanocarriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
   PubMed Web of Science ®Google Scholar
• DawidczykCMKimCParkJHState-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicinesJ Control Release201418713314424874289
   PubMed Web of Science ®Google Scholar
• DawidczykCMRussellLMSearsonPCNanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developmentsFront Chem201426925202689
   PubMed Web of Science ®Google Scholar
• RussellLMDawidczykCMSearsonPCQuantitative evaluation of the enhanced permeability and retention (EPR) effectMethods Mol Biol2017153024725428150206
   PubMedGoogle Scholar
• NgouneRPetersAvon ElverfeldtDWinklerKPützGAccumulating nanoparticles by EPR: A route of no returnJ Control Release2016238587027448444
   PubMed Web of Science ®Google Scholar
• ZhongYMengFDengCZhongZLigand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapyBiomacromolecules20141561955196924798476
   PubMed Web of Science ®Google Scholar
• WangXLiSShiYThe development of site-specific drug delivery nanocarriers based on receptor mediationJ Control Release201419313915324862317
   PubMed Web of Science ®Google Scholar
• RuoslahtiEPeptides as targeting elements and tissue penetration devices for nanoparticlesAdv Mater201224283747375622550056
   PubMed Web of Science ®Google Scholar
• AccardoAMorelliGReview peptide-targeted liposomes for selective drug delivery: advantages and problematic issuesBiopolymers2015104546247926010528
   PubMed Web of Science ®Google Scholar
• PasqualiniRKoivunenEKainRAminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesisCancer Res200060372272710676659
   PubMed Web of Science ®Google Scholar
• ShimJSKimJHChoHYIrreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcuminChem Biol200310869570412954328
   PubMedGoogle Scholar
• DunneMZhengJRosenblatJJaffrayDAAllenCAPN/CD13-targeting as a strategy to alter the tumor accumulation of liposomesJ Control Release2011154329830521640146
   PubMed Web of Science ®Google Scholar
• LuoLMHuangYZhaoBXAnti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxelBiomaterials20133441102111423127332
   PubMed Web of Science ®Google Scholar
• GraziadioAZandaMFrauSNGR tumor-homing peptides: Structural requirements for effective APN (CD13) targetingBioconjug Chem20162751332134027077642
   PubMed Web of Science ®Google Scholar
• HendrikxGde Saint-HubertMDijkgraafIMolecular imaging of angiogenesis after myocardial infarction by (111)In-DTPA-cNGR and (99m)Tc-sestamibi dual-isotope myocardial SPECTEJNMMI Res20155225853008
   PubMed Web of Science ®Google Scholar
• SoudyRAhmedSKaurKNGR peptide ligands for targeting CD13/APN identified through peptide array screening resemble fibronectin sequencesACS Comb Sci2012141159059923030271
   PubMed Web of Science ®Google Scholar
• SonSSinghaKKimWJBioreducible BPEI-SS-PEG-cNGR polymer as a tumor targeted nonviral gene carrierBiomaterials201031246344635420537703
   PubMed Web of Science ®Google Scholar
• ColomboMFiandraLAlessioGTumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodiesNat Commun201671381827991503
   PubMed Web of Science ®Google Scholar
• ChaplinDJOlivePLDurandREIntermittent blood flow in a murine tumor: radiobiological effectsCancer Res19874725976013791244
   PubMed Web of Science ®Google Scholar
• PaderaTPStollBRTooredmanJBPathology: cancer cells compress intratumour vesselsNature2004427697669514973470
   PubMed Web of Science ®Google Scholar
• JainRKMunnLLFukumuraDDissecting tumour pathophysiology using intravital microscopyNat Rev Cancer20022426627612001988
   PubMed Web of Science ®Google Scholar
• HeldinCHRubinKPietrasKOstmanAHigh interstitial fluid pressure – an obstacle in cancer therapyNat Rev Cancer200441080681315510161
   PubMed Web of Science ®Google Scholar
• SriramanSKAryasomayajulaBTorchilinVPBarriers to drug delivery in solid tumorsTissue Barriers20142e2952825068098
   PubMedGoogle Scholar
• MinchintonAITannockIFDrug penetration in solid tumoursNat Rev Cancer20066858359216862189
   PubMed Web of Science ®Google Scholar
• ShiNQQiXRXiangBZhangYA survey on “Trojan Horse” peptides: opportunities, issues and controlled entry to “Troy”J Control Release2014194537025151981
   PubMed Web of Science ®Google Scholar
• MaDXShiNQQiXRDistinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cellsInt J Pharm20114191–220020821843610
   PubMed Web of Science ®Google Scholar
• XiangBDongDWShiNQPSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancerBiomaterials201334286976699123777916
   PubMed Web of Science ®Google Scholar
• ShiNQGaoWXiangBQiXREnhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavageInt J Nanomedicine201271613162122619516
   PubMed Web of Science ®Google Scholar
• ShiNQQiXRTaming the wildness of “Trojan-Horse” peptides by charge-guided masking and protease-triggered demasking for the controlled delivery of antitumor agentsACS Appl Mater Interfaces2017912105191052928290666
   PubMed Web of Science ®Google Scholar
• MacewanSRChilkotiAHarnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agentsWiley Interdiscip Rev Nanomed Nanobiotechnol201351314822977001
   PubMed Web of Science ®Google Scholar
• MelikovKHaraAYamoahKEfficient entry of cell-penetrating peptide nona-arginine into adherent cells involves a transient increase in intracellular calciumBiochem J2015471222123026272944
   PubMedGoogle Scholar
• HaranGCohenRBarLKBarenholzYTransmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak basesBiochim Biophys Acta1993115122012158373796
   PubMed Web of Science ®Google Scholar
• WangXWangYChenXNGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cellsJ Control Release20091391566219470394
   PubMed Web of Science ®Google Scholar
• SawantRTorchilinVIntracellular transduction using cell-penetrating peptidesMol Biosyst20106462864020237640
   PubMed Web of Science ®Google Scholar
• FutakiSMembrane-permeable arginine-rich peptides and the trans-location mechanismsAdv Drug Deliv Rev200557454755815722163
   PubMed Web of Science ®Google Scholar
• SharminSIslamMZKaralMAEffects of lipid composition on the entry of cell-penetrating peptide oligoarginine into single vesiclesBiochemistry201655304154416527420912
   PubMed Web of Science ®Google Scholar
• FischerRBächleDFotin-MleczekMA targeted protease substrate for a quantitative determination of protease activities in the endolysosomal pathwayChembiochem2006791428143416871600
   PubMed Web of Science ®Google Scholar
• WenderPAMitchellDJPattabiramanKThe design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transportersProc Natl Acad Sci U S A20009724130031300811087855
   PubMed Web of Science ®Google Scholar
• CerratoCPKünnapuuKLangelÜCell-penetrating peptides with intracellular organelle targetingExpert Opin Drug Deliv201714224525527426871
   PubMed Web of Science ®Google Scholar
• RiezmanHWoodmanPGvan MeerGMarshMMolecular mechanisms of endocytosisCell19979167317389413982
   PubMed Web of Science ®Google Scholar
• ChenSTamYYCLinPJCInfluence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNAJ Control Release201623523624427238441
   PubMed Web of Science ®Google Scholar
• AllenTMChengWWHareJILaginhaKMPharmacokinetics and pharmacodynamics of lipidic nano-particles in cancerAnticancer Agents Med Chem20066651352317100556
   PubMedGoogle Scholar
• WongCStylianopoulosTCuiJMultistage nanoparticle delivery system for deep penetration into tumor tissueProc Natl Acad Sci U S A201110862426243121245339
   PubMed Web of Science ®Google Scholar
• MadaniFLindbergSLangelUFutakiSGräslundAMechanisms of cellular uptake of cell-penetrating peptidesJ Biophys2011201141472921687343
   PubMedGoogle Scholar
• ZaroJLVekichJETranTShenWCNuclear localization of cell-penetrating peptides is dependent on endocytosis rather than cytosolic delivery in CHO cellsMol Pharm20096233734419718791
   PubMed Web of Science ®Google Scholar
• WadiaJSStanRVDowdySFTransducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macro-pinocytosisNat Med200410331031514770178
   PubMed Web of Science ®Google Scholar
• RichardJPMelikovKBrooksHCellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptorsJ Biol Chem200528015153001530615687490
   PubMed Web of Science ®Google Scholar
• PotocnikSJJenkinsNMurphyTVHillMAMembrane cholesterol depletion with beta-cyclodextrin impairs pressure-induced contraction and calcium signalling in isolated skeletal muscle arteriolesJ Vasc Res200744429230217406121
   PubMed Web of Science ®Google Scholar
• DubikovskayaEAThorneSHPillowTHContagCHWenderPAOvercoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transportersProc Natl Acad Sci U S A200810534121281213318713866
   PubMed Web of Science ®Google Scholar
• WenderPAGalliherWCBhatNMTaxol-oligoarginine conjugates overcome drug resistance in-vitro in human ovarian carcinomaGynecol Oncol2012126111812322484398
   PubMed Web of Science ®Google Scholar
• VargasJRStanzlEGTengNNWenderPACell-penetrating, guanidinium-rich molecular transporters for overcoming efflux-mediated multidrug resistanceMol Pharm20141182553256524798708
   PubMed Web of Science ®Google Scholar
• CandanGMichiueHIshikawaSCombining poly-arginine with the hydrophobic counter-anion 4-(1-pyrenyl)-butyric acid for protein transduction in transdermal deliveryBiomaterials201233276468647522743600
   PubMed Web of Science ®Google Scholar
• ShahPPDesaiPRChannerDSinghMEnhanced skin permeation using polyarginine modified nanostructured lipid carriersJ Control Release2012161373574522617521
   PubMed Web of Science ®Google Scholar
• PhamWZhaoBQLoEHMedarovaZRosenBMooreACrossing the blood-brain barrier: a potential application of myristoylated polyarginine for in vivo neuroimagingNeuroimage200528128729216040255
   PubMed Web of Science ®Google Scholar
• YoonJYYangKJKimDEIntratympanic delivery of oligoarginine-conjugated nanoparticles as a gene (or drug) carrier to the inner earBiomaterials20157324325326414408
   PubMed Web of Science ®Google Scholar
• YamakiTUchidaMKuwaharaYEffect of poly-L-arginine on intestinal absorption of hydrophilic macromolecules in ratsBiol Pharm Bull201336349650023257956
   PubMed Web of Science ®Google Scholar